跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RETSEVMO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RETSEVMO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
RETSEVMO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 3, 2025
Approval ID
64976840012ba18c
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
64976840012ba18c
Drug Cima Aemps Name
RETSEVMO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1201527013
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Lilly S.A.
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Marketing Company Detail Path
/organization/lilly-sa
Authorization Date
2025-09-03
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 3, 2025
Approval ID
64976840012ba18c
Type
Standard
Back to CIMA-AEMPS Approvals
